Victory Capital Management
CTSO icon

Victory Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Victory Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-73,630
Closed -$729K – 2505
2020
Q2 		$729K Buy
73,630
+63,970
+662% +$587K ﹤0.01% 1862
2020
Q1 		$74K Sell
9,660
-5,569
-37% -$28.1K ﹤0.01% 2623
2019
Q4 		$59K Sell
15,229
-4,994
-25% -$21.8K ﹤0.01% 2600
2019
Q3 		$102K Buy
+20,223
New +$118K ﹤0.01% 2429

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's CTSO Position: Q3 2020 in Review

Victory Capital Management sold out of Cytosorbents Corp (CTSO) in Q3 2020, closing a stake of 73,630 shares — an estimated $729K sold.

Victory Capital Management first reported a position in CTSO in Q3 2019 and held it in 4 quarters. The position peaked at $729K in Q2 2020. 96 funds tracked by Wall St. Rank hold CTSO as of Q3 2020.

  • Victory Capital Management reported no remaining Cytosorbents Corp position as of Q3 2020 after selling out during the quarter.
  • Victory Capital Management sold 73,630 Cytosorbents Corp shares in Q3 2020, an estimated $729K.
  • Victory Capital Management first reported a position in Cytosorbents Corp in Q3 2019 and held it in 4 quarters.
  • Victory Capital Management's Cytosorbents Corp position peaked at $729K in Q2 2020.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2020.

Based on Victory Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.